Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:35 AM UTC
| NCT Number | NCT04614103 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 170 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT04614103 is currently recruiting participants. This phase2 study for lung cancer is actively seeking new participants at 27 locations across the United States. The study is sponsored by Iovance Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04614103 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04614103 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.